Home Antibody All anti-CARD8 antibodies
Also for CARD8 (NM_001184900)
|CARD8 antibody was raised against a synthetic peptide corresponding to amino acids at the C-terminus of human CARD8.|
||0.5~1.0 mg/ml (Lot Dependent)
||ELISA, WB: 2 and 4 ug/ml, ICC: 10 ug/ml, IF: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens caspase recruitment domain family, member 8 (CARD8), transcript variant 1|
|CARDINAL; DACAR; DAKAR; NDPP; NDPP1; TUCAN|
|Apoptosis is related to many diseases and development. Cell death signals are transduced by death domain (DD), death effector domain (DED), and caspase recruitment domain (CARD) containing molecules. CARD containing proteins include some caspases, Apaf-1, CARD4, IAPs, RICK, ARC, RAIDD, BCL-10, and ASC. A novel CARD-containing protein was recently identified and designated CARD8. This protein interacts with DRAL, a p53-responsive protein implicated in the induction of apoptosis (1,2), and caspase-1 and its related proteins ICEBERG and pesudo-ICE (3). Although there are conflicting reports on whether CARD8 acts a pro- or anti-apoptotic protein (2,4), it has been suggested that it functions as an adaptor molecule regulating caspase-1 and NF-kappaB activation.|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of CARD8 expression in K562 cell lysate with CARD8 antibody at (A) 2 and (B) 4 ug /ml.
Immunocytochemistry of CARD8 in K562 cells with CARD8 antibody at 10 ug/mL.